Study Data


MS Study

Project uploaded by: Swasti
Project ID: IMP_100040
Title: Kingdom-specific lipid unsaturation calibrates sequence evolution in membrane arm subunits of eukaryotic respiratory complexes
Project Description: Sequence evolution of protein complexes (PCs) is constrained by protein-protein interactions (PPIs). PPI-interfaces are predominantly conserved and hotspots for disease-related mutations. How do lipid-protein interactions (LPIs) constrain sequence evolution of membrane-PCs? We explore Respiratory Complexes (RCs) as a case study as these allow to compare sequence evolution in subunits exposed to both lipids in inner-mitochondrial membrane (IMM) and lipid-free aqueous matrix. We find that lipid-exposed surfaces of the IMM-subunits but not of the matrix subunits are populated with non-PPI disease-causing mutations signifying LPIs in stabilizing RCs. Further, IMM-subunits including their exposed surfaces show high intra-kingdom sequence conservation but remarkably diverge beyond. Molecular Dynamics simulation suggests contrasting LPIs of structurally superimposable but sequence-wise diverged IMM-exposed helices of Complex I (CI) subunit Ndufa1 from human and Arabidopsis depending on kingdom-specific unsaturation of cardiolipin fatty acyl chains. in cellulo assays consolidate inter-kingdom incompatibility of Ndufa1-helices due to the lipid-exposed amino acids. Plant-specific unsaturated fatty acids in human cells also trigger CI-instability. Taken together, we posit that altered LPIs calibrate sequence evolution at the IMM-arms of eukaryotic RCs.
Research Area: Biological Sciences
Funding Source: NIH grant, U2C- DK119886
Project Contributors: Pooja Gupta, Sristi Chakroborty, Arun K. Rathod, K. Ranjith Kumar, Shreya Bhat, Suparna Ghosh, Pallavi Rao T, Kameshwari Yele, Raman Bakthisaran, R. Nagaraj, Moutusi Manna & Swasti Raychaudhuri

Study uploaded by: Swasti
Study ID: IMS_100035
Title: Kingdom-specific lipid unsaturation calibrates sequence evolution in membrane arm subunits of eukaryotic respiratory complexes
Summary: Sequence evolution of protein complexes (PCs) is constrained by protein-protein interactions (PPIs). PPI-interfaces are predominantly conserved and hotspots for disease-related mutations. How do lipid-protein interactions (LPIs) constrain sequence evolution of membrane-PCs? We explore Respiratory Complexes (RCs) as a case study as these allow to compare sequence evolution in subunits exposed to both lipids in inner-mitochondrial membrane (IMM) and lipid-free aqueous matrix. We find that lipid-exposed surfaces of the IMM-subunits but not of the matrix subunits are populated with non-PPI disease-causing mutations signifying LPIs in stabilizing RCs. Further, IMM-subunits including their exposed surfaces show high intra-kingdom sequence conservation but remarkably diverge beyond. Molecular Dynamics simulation suggests contrasting LPIs of structurally superimposable but sequence-wise diverged IMM-exposed helices of Complex I (CI) subunit Ndufa1 from human and Arabidopsis depending on kingdom-specific unsaturation of cardiolipin fatty acyl chains. in cellulo assays consolidate inter-kingdom incompatibility of Ndufa1-helices due to the lipid-exposed amino acids. Plant-specific unsaturated fatty acids in human cells also trigger CI-instability. Taken together, we posit that altered LPIs calibrate sequence evolution at the IMM-arms of eukaryotic RCs.
Publication: https://www.nature.com/articles/s41467-025-57295-7
Release Date: July 8, 2025
Study Type: Mass Spectrometry (MS)
Data Type: Untargeted
IEC/IBSC Approval Number :

Sr.No Sample ID Sample Name Organism Source Sample Preparation Protocol Sample Type Experimental Condition Time of treatment Variant/Variety Gender Age Replicates Storage Conditions Extraction Protocol Number of files per sample
1 IMSM_101905 Experimental Blank-1 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -80°C until further use. LC buffer Blank 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
2 IMSM_101918 Experimental Blank-2 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -80°C until further use. LC buffer BLank 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
3 IMSM_101919 Experimental Blank-3 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -81°C until further use. LC buffer Blank 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
4 IMSM_101920 Experimental Blank-4 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -82°C until further use. LC buffer Blank 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
5 IMSM_101921 Experimental Blank-5 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -83°C until further use. LC buffer Blank 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
6 IMSM_101922 Experimental Blank-6 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -84°C until further use. LC buffer Blank 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
7 IMSM_101923 Experimental Blank-7 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -85°C until further use. LC buffer Blank 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
8 IMSM_101924 Experimental Blank-8 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -86°C until further use. LC buffer Blank 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
9 IMSM_101925 Experimental Blank-9 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -87°C until further use. LC buffer Blank 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
10 IMSM_101926 Experimental Blank-10 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -88°C until further use. LC buffer Blank 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
11 IMSM_101927 Experimental Blank-11 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -89°C until further use. LC buffer Blank 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
12 IMSM_101928 Experimental Blank-12 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -90°C until further use. LC buffer Blank 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
13 IMSM_101929 Experimental Blank-13 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -91°C until further use. LC buffer Blank 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
14 IMSM_101930 Experimental Blank-14 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -92°C until further use. LC buffer Blank 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
15 IMSM_101931 Experimental Blank-15 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -93°C until further use. LC buffer Blank 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
16 IMSM_101932 Experimental Blank-16 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -94°C until further use. LC buffer Blank 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
17 IMSM_101933 Experimental Blank-17 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -95°C until further use. LC buffer Blank 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
18 IMSM_101934 Experimental Blank-18 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -96°C until further use. LC buffer Blank 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
19 IMSM_101935 Experimental Blank-19 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -97°C until further use. LC buffer Blank 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
20 IMSM_101936 Experimental Blank-20 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -98°C until further use. LC buffer Blank 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
21 IMSM_101937 Experimental Blank-21 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -99°C until further use. LC buffer Blank 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
22 IMSM_101938 Experimental Blank-22 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -100°C until further use. LC buffer Blank 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
23 IMSM_101939 Experimental Blank-23 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -101°C until further use. LC buffer Blank 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
24 IMSM_101940 Experimental Blank-24 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -102°C until further use. LC buffer Blank 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
25 IMSM_101941 Experimental Blank-25 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -103°C until further use. LC buffer Blank 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
26 IMSM_101942 Experimental Blank-26 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -104°C until further use. LC buffer Blank 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
27 IMSM_101943 Experimental Blank-27 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -105°C until further use. LC buffer Blank 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
28 IMSM_101944 Experimental Blank-28 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -106°C until further use. LC buffer Blank 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
29 IMSM_101945 Experimental Blank-29 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -107°C until further use. LC buffer Blank 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
30 IMSM_101946 Experimental Blank-30 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -108°C until further use. LC buffer Blank 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
31 IMSM_101947 Experimental Blank-31 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -109°C until further use. LC buffer Blank 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
32 IMSM_101948 Experimental Blank-32 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -110°C until further use. LC buffer Blank 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
33 IMSM_101949 Experimental Blank-33 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -111°C until further use. LC buffer Blank 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
34 IMSM_101950 Experimental Blank-34 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -112°C until further use. LC buffer Blank 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
35 IMSM_101951 Experimental Blank-35 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -113°C until further use. LC buffer Blank 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
36 IMSM_101952 Experimental Blank-36 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -114°C until further use. LC buffer Blank 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
37 IMSM_101953 Experimental Blank-37 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -115°C until further use. LC buffer Blank 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
38 IMSM_101954 Experimental Blank-38 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -116°C until further use. LC buffer Blank 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
39 IMSM_101955 Experimental Blank-40 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -117°C until further use. LC buffer Blank 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
40 IMSM_101956 Experimental Blank-41 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -118°C until further use. LC buffer Blank 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
41 IMSM_101957 Experimental Blank-42 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -119°C until further use. LC buffer Blank 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
42 IMSM_101958 Experimental Blank-43 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -120°C until further use. LC buffer Blank 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
43 IMSM_101959 Experimental Blank-44 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -121°C until further use. LC buffer Blank 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
44 IMSM_101960 Experimental Blank-45 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -122°C until further use. LC buffer Blank 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
45 IMSM_101961 HEK293T-BSA-R1 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -123°C until further use. HEK293T cultured cells Control 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
46 IMSM_101962 HEK293T-BSA-R2 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -124°C until further use. HEK293T cultured cells Control 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
47 IMSM_101963 HEK293T-BSA-R3 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -125°C until further use. HEK293T cultured cells Control 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
48 IMSM_101964 HEK293T-BSA-R4 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -126°C until further use. HEK293T cultured cells Control 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
49 IMSM_101965 HEK293T-BSA-R5 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -127°C until further use. HEK293T cultured cells Control 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
50 IMSM_101966 HEK293T-BSA-R6 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -128°C until further use. HEK293T cultured cells Control 0 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
51 IMSM_101967 HEK293T-18 2-treated-R1 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -129°C until further use. HEK293T cultured cells Linoleic acid treatment 72 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
52 IMSM_101968 HEK293T-18 2-treated-R2 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -130°C until further use. HEK293T cultured cells Linoleic acid treatment 72 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
53 IMSM_101969 HEK293T-18 2-treated-R3 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -131°C until further use. HEK293T cultured cells Linoleic acid treatment 72 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
54 IMSM_101970 HEK293T-18 2-treated-R4 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -132°C until further use. HEK293T cultured cells Linoleic acid treatment 72 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
55 IMSM_101971 HEK293T-18 2-treated-R5 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -133°C until further use. HEK293T cultured cells Linoleic acid treatment 72 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
56 IMSM_101972 HEK293T-18 2-treated-R6 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -134°C until further use. HEK293T cultured cells Linoleic acid treatment 72 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
57 IMSM_101973 HEK293T-18 3-treated-R1 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -135°C until further use. HEK293T cultured cells Linoleic acid treatment 72 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
58 IMSM_101974 HEK293T-18 3-treated-R2 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -136°C until further use. HEK293T cultured cells Linoleic acid treatment 72 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
59 IMSM_101975 HEK293T-18 3-treated-R3 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -137°C until further use. HEK293T cultured cells Linoleic acid treatment 72 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
60 IMSM_101976 HEK293T-18 3-treated-R4 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -138°C until further use. HEK293T cultured cells Linoleic acid treatment 72 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
61 IMSM_101977 HEK293T-18 3-treated-R5 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -139°C until further use. HEK293T cultured cells Linoleic acid treatment 72 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2
62 IMSM_101978 HEK293T-18 3-treated-R6 Homo sapiens HEK293T cultured cells 150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -140°C until further use. HEK293T cultured cells Linoleic acid treatment 72 hours NA NA NA NA Processing Storage Conditions 4℃ and Extract Storage -80℃

NA

2

Sr.No MS Exp ID Sample Name/ID Mass Spectrometer Type MS Instrument Name MS Instrument type MS Ionization Method Ion Mode/Scan Polarity Data Transformation (Software/s Used)
1 IME_101145 Experimental Blank-1 / IMSM_101905 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
2 IME_101146 Experimental Blank-1 / IMSM_101905 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
3 IME_101147 Experimental Blank-2 / IMSM_101918 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
4 IME_101148 Experimental Blank-2 / IMSM_101918 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
5 IME_101149 Experimental Blank-3 / IMSM_101919 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
6 IME_101150 Experimental Blank-3 / IMSM_101919 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
7 IME_101151 Experimental Blank-4 / IMSM_101920 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
8 IME_101152 Experimental Blank-4 / IMSM_101920 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
9 IME_101153 Experimental Blank-5 / IMSM_101921 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
10 IME_101154 Experimental Blank-5 / IMSM_101921 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
11 IME_101155 Experimental Blank-6 / IMSM_101922 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
12 IME_101156 Experimental Blank-6 / IMSM_101922 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
13 IME_101157 Experimental Blank-7 / IMSM_101923 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
14 IME_101158 Experimental Blank-7 / IMSM_101923 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
15 IME_101159 Experimental Blank-8 / IMSM_101924 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
16 IME_101160 Experimental Blank-8 / IMSM_101924 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
17 IME_101161 Experimental Blank-9 / IMSM_101925 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
18 IME_101162 Experimental Blank-9 / IMSM_101925 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
19 IME_101163 Experimental Blank-10 / IMSM_101926 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
20 IME_101164 Experimental Blank-10 / IMSM_101926 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
21 IME_101165 Experimental Blank-11 / IMSM_101927 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
22 IME_101166 Experimental Blank-11 / IMSM_101927 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
23 IME_101167 Experimental Blank-12 / IMSM_101928 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
24 IME_101168 Experimental Blank-12 / IMSM_101928 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
25 IME_101169 Experimental Blank-13 / IMSM_101929 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
26 IME_101170 Experimental Blank-13 / IMSM_101929 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
27 IME_101171 Experimental Blank-14 / IMSM_101930 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
28 IME_101172 Experimental Blank-14 / IMSM_101930 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
29 IME_101173 Experimental Blank-15 / IMSM_101931 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
30 IME_101174 Experimental Blank-15 / IMSM_101931 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
31 IME_101175 Experimental Blank-16 / IMSM_101932 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
32 IME_101176 Experimental Blank-16 / IMSM_101932 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
33 IME_101177 Experimental Blank-17 / IMSM_101933 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
34 IME_101178 Experimental Blank-17 / IMSM_101933 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
35 IME_101179 Experimental Blank-18 / IMSM_101934 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
36 IME_101180 Experimental Blank-18 / IMSM_101934 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
37 IME_101181 Experimental Blank-19 / IMSM_101935 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
38 IME_101182 Experimental Blank-19 / IMSM_101935 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
39 IME_101183 Experimental Blank-20 / IMSM_101936 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
40 IME_101184 Experimental Blank-20 / IMSM_101936 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
41 IME_101185 Experimental Blank-21 / IMSM_101937 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
42 IME_101186 Experimental Blank-21 / IMSM_101937 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
43 IME_101187 Experimental Blank-22 / IMSM_101938 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
44 IME_101188 Experimental Blank-22 / IMSM_101938 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
45 IME_101189 Experimental Blank-23 / IMSM_101939 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
46 IME_101190 Experimental Blank-23 / IMSM_101939 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
47 IME_101191 Experimental Blank-24 / IMSM_101940 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
48 IME_101192 Experimental Blank-24 / IMSM_101940 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
49 IME_101193 Experimental Blank-25 / IMSM_101941 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
50 IME_101194 Experimental Blank-25 / IMSM_101941 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
51 IME_101195 Experimental Blank-26 / IMSM_101942 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
52 IME_101196 Experimental Blank-26 / IMSM_101942 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
53 IME_101197 Experimental Blank-27 / IMSM_101943 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
54 IME_101198 Experimental Blank-27 / IMSM_101943 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
55 IME_101199 Experimental Blank-28 / IMSM_101944 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
56 IME_101200 Experimental Blank-28 / IMSM_101944 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
57 IME_101201 Experimental Blank-29 / IMSM_101945 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
58 IME_101202 Experimental Blank-29 / IMSM_101945 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
59 IME_101203 Experimental Blank-30 / IMSM_101946 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
60 IME_101204 Experimental Blank-30 / IMSM_101946 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
61 IME_101205 Experimental Blank-31 / IMSM_101947 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
62 IME_101206 Experimental Blank-31 / IMSM_101947 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
63 IME_101207 Experimental Blank-32 / IMSM_101948 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
64 IME_101208 Experimental Blank-32 / IMSM_101948 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
65 IME_101209 Experimental Blank-33 / IMSM_101949 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
66 IME_101210 Experimental Blank-33 / IMSM_101949 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
67 IME_101211 Experimental Blank-34 / IMSM_101950 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
68 IME_101212 Experimental Blank-34 / IMSM_101950 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
69 IME_101213 Experimental Blank-35 / IMSM_101951 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
70 IME_101214 Experimental Blank-35 / IMSM_101951 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
71 IME_101215 Experimental Blank-36 / IMSM_101952 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
72 IME_101216 Experimental Blank-36 / IMSM_101952 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
73 IME_101217 Experimental Blank-37 / IMSM_101953 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
74 IME_101218 Experimental Blank-37 / IMSM_101953 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
75 IME_101219 Experimental Blank-38 / IMSM_101954 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
76 IME_101220 Experimental Blank-38 / IMSM_101954 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
77 IME_101221 Experimental Blank-40 / IMSM_101955 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
78 IME_101222 Experimental Blank-40 / IMSM_101955 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
79 IME_101223 Experimental Blank-41 / IMSM_101956 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
80 IME_101224 Experimental Blank-41 / IMSM_101956 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
81 IME_101225 Experimental Blank-42 / IMSM_101957 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
82 IME_101226 Experimental Blank-42 / IMSM_101957 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
83 IME_101227 Experimental Blank-43 / IMSM_101958 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
84 IME_101228 Experimental Blank-43 / IMSM_101958 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
85 IME_101229 Experimental Blank-44 / IMSM_101959 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
86 IME_101230 Experimental Blank-44 / IMSM_101959 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
87 IME_101231 Experimental Blank-45 / IMSM_101960 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
88 IME_101232 Experimental Blank-45 / IMSM_101960 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
89 IME_101233 HEK293T-BSA-R1 / IMSM_101961 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
90 IME_101234 HEK293T-BSA-R1 / IMSM_101961 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
91 IME_101235 HEK293T-BSA-R2 / IMSM_101962 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
92 IME_101236 HEK293T-BSA-R2 / IMSM_101962 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
93 IME_101237 HEK293T-BSA-R3 / IMSM_101963 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
94 IME_101238 HEK293T-BSA-R3 / IMSM_101963 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
95 IME_101239 HEK293T-BSA-R4 / IMSM_101964 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
96 IME_101240 HEK293T-BSA-R4 / IMSM_101964 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
97 IME_101241 HEK293T-BSA-R5 / IMSM_101965 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
98 IME_101242 HEK293T-BSA-R5 / IMSM_101965 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
99 IME_101243 HEK293T-BSA-R6 / IMSM_101966 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
100 IME_101244 HEK293T-BSA-R6 / IMSM_101966 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
101 IME_101245 HEK293T-18 2-treated-R1 / IMSM_101967 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
102 IME_101246 HEK293T-18 2-treated-R1 / IMSM_101967 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
103 IME_101247 HEK293T-18 2-treated-R2 / IMSM_101968 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
104 IME_101248 HEK293T-18 2-treated-R2 / IMSM_101968 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
105 IME_101249 HEK293T-18 2-treated-R3 / IMSM_101969 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
106 IME_101250 HEK293T-18 2-treated-R3 / IMSM_101969 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
107 IME_101251 HEK293T-18 2-treated-R4 / IMSM_101970 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
108 IME_101252 HEK293T-18 2-treated-R4 / IMSM_101970 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
109 IME_101253 HEK293T-18 2-treated-R5 / IMSM_101971 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
110 IME_101254 HEK293T-18 2-treated-R5 / IMSM_101971 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
111 IME_101255 HEK293T-18 2-treated-R6 / IMSM_101972 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
112 IME_101256 HEK293T-18 2-treated-R6 / IMSM_101972 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
113 IME_101257 HEK293T-18 3-treated-R1 / IMSM_101973 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
114 IME_101258 HEK293T-18 3-treated-R1 / IMSM_101973 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
115 IME_101259 HEK293T-18 3-treated-R2 / IMSM_101974 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
116 IME_101260 HEK293T-18 3-treated-R2 / IMSM_101974 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
117 IME_101261 HEK293T-18 3-treated-R3 / IMSM_101975 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
118 IME_101262 HEK293T-18 3-treated-R3 / IMSM_101975 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
119 IME_101263 HEK293T-18 3-treated-R4 / IMSM_101976 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
120 IME_101264 HEK293T-18 3-treated-R4 / IMSM_101976 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
121 IME_101265 HEK293T-18 3-treated-R5 / IMSM_101977 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
122 IME_101266 HEK293T-18 3-treated-R5 / IMSM_101977 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
123 IME_101267 HEK293T-18 3-treated-R6 / IMSM_101978 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43
124 IME_101268 HEK293T-18 3-treated-R6 / IMSM_101978 LCMS (Liquid Chromatography- Mass Spectrometry) ABI Sciex 6500 QTrap|MS_1002581 Triple quadrupole Electrospray Ionization - ESI Negative Analytics version 3.3.1.43

Sr.No First name Last name Email Organization Designation
1 Swasti Raychaudhuri rcswasti@ccmb.res.in CSIR-Centre for Cellular & Molecular Biology principal_investigator

Sr.No ftprun ID MS Exp ID MS Data Files
1 IMR_101749 IME_101145 Blank-1.wiff
2 IMR_101750 IME_101146 Blank-1.wiff.scan
3 IMR_101751 IME_101147 Blank-2.wiff
4 IMR_101752 IME_101148 Blank-2.wiff.scan
5 IMR_101753 IME_101149 Blank-3.wiff
6 IMR_101754 IME_101150 Blank-3.wiff.scan
7 IMR_101755 IME_101151 Blank-4.wiff
8 IMR_101756 IME_101152 Blank-4.wiff.scan
9 IMR_101757 IME_101153 Blank-5.wiff
10 IMR_101758 IME_101154 Blank-5.wiff.scan
11 IMR_101759 IME_101155 Blank-6.wiff
12 IMR_101760 IME_101156 Blank-6.wiff.scan
13 IMR_101761 IME_101157 Blank-7.wiff
14 IMR_101762 IME_101158 Blank-7.wiff.scan
15 IMR_101763 IME_101159 Blank-8.wiff
16 IMR_101764 IME_101160 Blank-8.wiff.scan
17 IMR_101765 IME_101161 Blank-9.wiff
18 IMR_101766 IME_101162 Blank-9.wiff.scan
19 IMR_101767 IME_101163 Blank-10.wiff
20 IMR_101768 IME_101164 Blank-10.wiff.scan
21 IMR_101769 IME_101165 Blank-11.wiff
22 IMR_101770 IME_101166 Blank-11.wiff.scan
23 IMR_101771 IME_101167 Blank-12.wiff
24 IMR_101772 IME_101168 Blank-12.wiff.scan
25 IMR_101773 IME_101169 Blank-13.wiff
26 IMR_101774 IME_101170 Blank-13.wiff.scan
27 IMR_101775 IME_101171 Blank-14.wiff
28 IMR_101776 IME_101172 Blank-14.wiff.scan
29 IMR_101777 IME_101173 Blank-15.wiff
30 IMR_101778 IME_101174 Blank-15.wiff.scan
31 IMR_101779 IME_101175 Blank-16.wiff
32 IMR_101780 IME_101176 Blank-16.wiff.scan
33 IMR_101781 IME_101177 Blank-17.wiff
34 IMR_101782 IME_101178 Blank-17.wiff.scan
35 IMR_101783 IME_101179 Blank-18.wiff
36 IMR_101784 IME_101180 Blank-18.wiff.scan
37 IMR_101785 IME_101181 Blank-19.wiff
38 IMR_101786 IME_101182 Blank-19.wiff.scan
39 IMR_101787 IME_101183 Blank-20.wiff
40 IMR_101788 IME_101184 Blank-20.wiff.scan
41 IMR_101789 IME_101185 Blank-21.wiff
42 IMR_101790 IME_101186 Blank-21.wiff.scan
43 IMR_101791 IME_101187 Blank-22.wiff
44 IMR_101792 IME_101188 Blank-22.wiff.scan
45 IMR_101793 IME_101189 Blank-23.wiff
46 IMR_101794 IME_101190 Blank-23.wiff.scan
47 IMR_101795 IME_101191 Blank-24.wiff
48 IMR_101796 IME_101192 Blank-24.wiff.scan
49 IMR_101797 IME_101193 Blank-25.wiff
50 IMR_101798 IME_101194 Blank-25.wiff.scan
51 IMR_101799 IME_101195 Blank-26.wiff
52 IMR_101800 IME_101196 Blank-26.wiff.scan
53 IMR_101801 IME_101197 Blank-27.wiff
54 IMR_101802 IME_101198 Blank-27.wiff.scan
55 IMR_101803 IME_101199 Blank-28.wiff
56 IMR_101804 IME_101200 Blank-28.wiff.scan
57 IMR_101805 IME_101201 Blank-29.wiff
58 IMR_101806 IME_101202 Blank-29.wiff.scan
59 IMR_101807 IME_101203 Blank-30.wiff
60 IMR_101808 IME_101204 Blank-30.wiff.scan
61 IMR_101809 IME_101205 Blank-31.wiff
62 IMR_101810 IME_101206 Blank-31.wiff.scan
63 IMR_101811 IME_101207 Blank-32.wiff
64 IMR_101812 IME_101208 Blank-32.wiff.scan
65 IMR_101813 IME_101209 Blank-33.wiff
66 IMR_101814 IME_101210 Blank-33.wiff.scan
67 IMR_101815 IME_101211 Blank-34.wiff
68 IMR_101816 IME_101212 Blank-34.wiff.scan
69 IMR_101817 IME_101213 Blank-35.wiff
70 IMR_101818 IME_101214 Blank-35.wiff.scan
71 IMR_101819 IME_101215 Blank-36.wiff
72 IMR_101820 IME_101216 Blank-36.wiff.scan
73 IMR_101821 IME_101217 Blank-37.wiff
74 IMR_101822 IME_101218 Blank-37.wiff.scan
75 IMR_101823 IME_101219 Blank-38.wiff
76 IMR_101824 IME_101220 Blank-38.wiff.scan
77 IMR_101825 IME_101221 Blank-39.wiff
78 IMR_101826 IME_101222 Blank-39.wiff.scan
79 IMR_101827 IME_101223 Blank-40.wiff
80 IMR_101828 IME_101224 Blank-40.wiff.scan
81 IMR_101829 IME_101225 Blank-41.wiff
82 IMR_101830 IME_101226 Blank-41.wiff.scan
83 IMR_101831 IME_101227 Blank-42.wiff
84 IMR_101832 IME_101228 Blank-42.wiff.scan
85 IMR_101833 IME_101229 Blank-43.wiff
86 IMR_101834 IME_101230 Blank-43.wiff.scan
87 IMR_101835 IME_101231 Blank-44.wiff
88 IMR_101836 IME_101232 Blank-44.wiff.scan
89 IMR_101837 IME_101233 HEK-BSA-R1.wiff
90 IMR_101838 IME_101234 HEK-BSA-R1.wiff.scan
91 IMR_101839 IME_101235 HEK-BSA-R2.wiff
92 IMR_101840 IME_101236 HEK-BSA-R2.wiff.scan
93 IMR_101841 IME_101237 HEK-BSA-R3.wiff
94 IMR_101842 IME_101238 HEK-BSA-R3.wiff.scan
95 IMR_101843 IME_101239 HEK-BSA-R4.wiff
96 IMR_101844 IME_101240 HEK-BSA-R4.wiff.scan
97 IMR_101845 IME_101241 HEK-BSA-R5.wiff
98 IMR_101846 IME_101242 HEK-BSA-R5.wiff.scan
99 IMR_101847 IME_101243 HEK-BSA-R6.wiff
100 IMR_101848 IME_101244 HEK-BSA-R6.wiff.scan
101 IMR_101849 IME_101245 HEK-18-2-R1.wiff
102 IMR_101850 IME_101246 HEK-18-2-R1.wiff.scan
103 IMR_101851 IME_101247 HEK-18-3-R1.wiff
104 IMR_101852 IME_101248 HEK-18-3-R1.wiff.scan
105 IMR_101853 IME_101249 HEK-18-2-R2.wiff
106 IMR_101854 IME_101250 HEK-18-2-R2.wiff.scan
107 IMR_101855 IME_101251 HEK-18-3-R2.wiff
108 IMR_101856 IME_101252 HEK-18-3-R2.wiff.scan
109 IMR_101857 IME_101253 HEK-18-2-R3.wiff
110 IMR_101858 IME_101254 HEK-18-2-R3.wiff.scan
111 IMR_101859 IME_101255 HEK-18-3-R3.wiff
112 IMR_101860 IME_101256 HEK-18-3-R3.wiff.scan
113 IMR_101861 IME_101257 HEK-18-2-R4.wiff
114 IMR_101862 IME_101258 HEK-18-2-R4.wiff.scan
115 IMR_101863 IME_101259 HEK-18-3-R4.wiff
116 IMR_101864 IME_101260 HEK-18-3-R4.wiff.scan
117 IMR_101865 IME_101261 HEK-18-2-R5.wiff
118 IMR_101866 IME_101262 HEK-18-2-R5.wiff.scan
119 IMR_101867 IME_101263 HEK-18-3-R5.wiff
120 IMR_101868 IME_101264 HEK-18-3-R5.wiff.scan
121 IMR_101869 IME_101265 HEK-18-2-R6.wiff
122 IMR_101870 IME_101266 HEK-18-2-R6.wiff.scan
123 IMR_101871 IME_101267 HEK-18-3-R6.wiff
124 IMR_101872 IME_101268 HEK-18-3-R6.wiff.scan

Download Metabolite/Compound

Sr.No Structure Details
1 Molecular Structure

CL 16:1_16:1_16:1_16:1

CHEBI ID: NA

PubChem ID: 131767780

Chemical Formula: C73H134O17P2

Smiles: CCCCCC/C=C\CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC/C=C\CCCCCC)COP(=O)(OCC(O)COP(=O)(OC[C@H](OC(=O)CCCCCCC/C=C\CCCCCC)COC(=O)CCCCCCC/C=C\CCCCCC)O)O

InChI: InChI=1S/C73H134O17P2/c1-5-9-13-17-21-25-29-33-37-41-45-49-53-57-70(75)83-63-68(89-72(77)59-55-51-47-43-39-35-31-27-23-19-15-11-7-3)65-87-91(79,80)85-61-67(74)62-86-92(81,82)88-66-69(90-73(78)60-56-52-48-44-40-36-32-28-24-20-16-12-8-4)64-84-71(76)58-54-50-46-42-38-34-30-26-22-18-14-10-6-2/h25-32,67-69,74H,5-24,33-66H2,1-4H3,(H,79,80)(H,81,82)/b29-25-,30-26-,31-27-,32-28-/t68-,69-/m1/s1

Mass to charge: 1343.9

Retention Time: 35.4

2 Molecular Structure

CL 16:0_16:0_16:0_18:1

CHEBI ID: NA

PubChem ID: 118701872

Chemical Formula: C77H134O17P2

Smiles: CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC)O)OC(=O)CCCCCCCCCCCCCCC

InChI: InChI=1S/C75H144O17P2/c1-5-9-13-17-21-25-29-33-34-38-42-46-50-54-58-62-75(80)92-71(66-86-73(78)60-56-52-48-44-40-36-31-27-23-19-15-11-7-3)68-90-94(83,84)88-64-69(76)63-87-93(81,82)89-67-70(91-74(79)61-57-53-49-45-41-37-32-28-24-20-16-12-8-4)65-85-72(77)59-55-51-47-43-39-35-30-26-22-18-14-10-6-2/h33-34,69-71,76H,5-32,35-68H2,1-4H3,(H,81,82)(H,83,84)/b34-33-/t69-,70+,71+/m0/s1

Mass to charge: 1377.9

Retention Time: 39.2

3 Molecular Structure

CL 16:0_16:1_16:1_18:2

CHEBI ID: NA

PubChem ID: 131766973

Chemical Formula: C75H138O17P2

Smiles: CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\CCCCCC)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC)O)OC(=O)CCCCCCC/C=C\CCCCCC

InChI: InChI=1S/C75H138O17P2/c1-5-9-13-17-21-25-29-33-34-38-42-46-50-54-58-62-75(80)92-71(66-86-73(78)60-56-52-48-44-40-36-31-27-23-19-15-11-7-3)68-90-94(83,84)88-64-69(76)63-87-93(81,82)89-67-70(91-74(79)61-57-53-49-45-41-37-32-28-24-20-16-12-8-4)65-85-72(77)59-55-51-47-43-39-35-30-26-22-18-14-10-6-2/h21,25,27-28,31-34,69-71,76H,5-20,22-24,26,29-30,35-68H2,1-4H3,(H,81,82)(H,83,84)/b25-21-,31-27-,32-28-,34-33-/t69-,70+,71+/m0/s1

Mass to charge: 1371.9

Retention Time: 36.3

4 Molecular Structure

CL 16:1_16:1_18:2_16:1

CHEBI ID: NA

PubChem ID: 131767810

Chemical Formula: C75H136O17P2

Smiles: CCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCC/C=C\CCCCCC)O)OC(=O)CCCCCCC/C=C\CCCCCC

InChI: InChI=1S/C75H136O17P2/c1-5-9-13-17-21-25-29-33-34-38-40-44-48-52-56-60-73(78)86-66-71(92-75(80)62-58-54-50-46-42-37-32-28-24-20-16-12-8-4)68-90-94(83,84)88-64-69(76)63-87-93(81,82)89-67-70(91-74(79)61-57-53-49-45-41-36-31-27-23-19-15-11-7-3)65-85-72(77)59-55-51-47-43-39-35-30-26-22-18-14-10-6-2/h21,25-28,30-34,69-71,76H,5-20,22-24,29,35-68H2,1-4H3,(H,81,82)(H,83,84)/b25-21-,30-26-,31-27-,32-28-,34-33-/t69-,70+,71+/m0/s1

Mass to charge: 1369.9

Retention Time: 35.6

5 Molecular Structure

CL 16:0_16:1_16:1_18:3

CHEBI ID: NA

PubChem ID: 138284445

Chemical Formula: C75H136O17P2

Smiles: CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC/C=C\CCCCCC)COP(=O)(O)OCC(COP(=O)(O)OCC(COC(=O)CCCCCCC/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCC/C=C\CCCCCC)O

InChI: InChI=1S/C75H136O17P2/c1-5-9-13-17-21-25-29-33-34-38-40-44-48-52-56-60-73(78)86-66-71(92-75(80)62-58-54-50-46-42-37-32-28-24-20-16-12-8-4)68-90-94(83,84)88-64-69(76)63-87-93(81,82)89-67-70(91-74(79)61-57-53-49-45-41-36-31-27-23-19-15-11-7-3)65-85-72(77)59-55-51-47-43-39-35-30-26-22-18-14-10-6-2/h9,13,21,25-26,28,30,32-34,69-71,76H,5-8,10-12,14-20,22-24,27,29,31,35-68H2,1-4H3,(H,81,82)(H,83,84)/b13-9-,25-21-,30-26-,32-28-,34-33-

Mass to charge: 1369.9

Retention Time: 35.6

6 Molecular Structure

CL 16:0_16:0_18:1_18:1/ CL 16:0_16:1_18:0_18:1

CHEBI ID: NA

PubChem ID: 138125708

Chemical Formula: C77H146O17P2

Smiles: CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(COP(=O)(O)OCC(COC(=O)CCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC)O)OC(=O)CCCCCCCCCCCCCCC

InChI: InChI=1S/C77H146O17P2/c1-5-9-13-17-21-25-29-33-35-39-42-46-50-54-58-62-75(80)88-68-73(94-77(82)64-60-56-52-48-44-40-36-34-30-26-22-18-14-10-6-2)70-92-96(85,86)90-66-71(78)65-89-95(83,84)91-69-72(93-76(81)63-59-55-51-47-43-38-32-28-24-20-16-12-8-4)67-87-74(79)61-57-53-49-45-41-37-31-27-23-19-15-11-7-3/h33-36,71-73,78H,5-32,37-70H2,1-4H3,(H,83,84)(H,85,86)/b35-33-,36-34-

Mass to charge: 1403.9

Retention Time: 39.3

7 Molecular Structure

CL 16:1_16:1_18:1_18:1

CHEBI ID: NA

PubChem ID: 138272266

Chemical Formula: C77H142O17P2

Smiles: CCCCCCCC/C=C\CCCCCCCC(=O)OCC(COP(=O)(O)OCC(COP(=O)(O)OCC(COC(=O)CCCCCCC/C=C\CCCCCC)OC(=O)CCCCCCC/C=C\CCCCCC)O)OC(=O)CCCCCCC/C=C\CCCCCCCC

InChI: InChI=1S/C77H142O17P2/c1-5-9-13-17-21-25-29-33-35-39-42-46-50-54-58-62-75(80)88-68-73(94-77(82)64-60-56-52-48-44-40-36-34-30-26-22-18-14-10-6-2)70-92-96(85,86)90-66-71(78)65-89-95(83,84)91-69-72(93-76(81)63-59-55-51-47-43-38-32-28-24-20-16-12-8-4)67-87-74(79)61-57-53-49-45-41-37-31-27-23-19-15-11-7-3/h27-28,31-36,71-73,78H,5-26,29-30,37-70H2,1-4H3,(H,83,84)(H,85,86)/b31-27-,32-28-,35-33-,36-34-

Mass to charge: 1399.9

Retention Time: 37.0

8 Molecular Structure

CL 16:0_16:0_18:1_18:3

CHEBI ID: NA

PubChem ID: 138292608

Chemical Formula: C77H142O17P2

Smiles: CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(COP(=O)(O)OCC(COC(=O)CCCCCCC/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCC/C=C\CCCCCCCC)O)OC(=O)CCCCCCCCCCCCCCC

InChI: InChI=1S/C77H142O17P2/c1-5-9-13-17-21-25-29-33-35-39-42-46-50-54-58-62-75(80)88-68-73(94-77(82)64-60-56-52-48-44-40-36-34-30-26-22-18-14-10-6-2)70-92-96(85,86)90-66-71(78)65-89-95(83,84)91-69-72(93-76(81)63-59-55-51-47-43-38-32-28-24-20-16-12-8-4)67-87-74(79)61-57-53-49-45-41-37-31-27-23-19-15-11-7-3/h9,13,21,25,33-36,71-73,78H,5-8,10-12,14-20,22-24,26-32,37-70H2,1-4H3,(H,83,84)(H,85,86)/b13-9-,25-21-,35-33-,36-34-

Mass to charge: 1399.9

Retention Time: 37.0

9 Molecular Structure

CL 16:1_16:1_18:1_18:2/ CL 16:0_16:1_18:2_18:2

CHEBI ID: NA

PubChem ID: 138195581

Chemical Formula: C77H140O17P2

Smiles: CCCCCCCC/C=C\CCCCCCCC(=O)OC(COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)COP(=O)(O)OCC(COP(=O)(O)OCC(COC(=O)CCCCCCC/C=C\CCCCCC)OC(=O)CCCCCCC/C=C\CCCCCC)O

InChI: InChI=1S/C77H140O17P2/c1-5-9-13-17-21-25-29-33-35-39-42-46-50-54-58-62-75(80)88-68-73(94-77(82)64-60-56-52-48-44-40-36-34-30-26-22-18-14-10-6-2)70-92-96(85,86)90-66-71(78)65-89-95(83,84)91-69-72(93-76(81)63-59-55-51-47-43-38-32-28-24-20-16-12-8-4)67-87-74(79)61-57-53-49-45-41-37-31-27-23-19-15-11-7-3/h21,25,27-28,31-36,71-73,78H,5-20,22-24,26,29-30,37-70H2,1-4H3,(H,83,84)(H,85,86)/b25-21-,31-27-,32-28-,35-33-,36-34-

Mass to charge: 1397.9

Retention Time: 36.7

10 Molecular Structure

CL 16:0_16:0_18:2_18:3/ CL 16:0_16:1_18:1_18:3/ CL 16:1_16:1_18:0_18:3

CHEBI ID: NA

PubChem ID: 138127050

Chemical Formula: C77H140O17P2

Smiles: CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(COP(=O)(O)OCC(COC(=O)CCCCCCC/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC)O)OC(=O)CCCCCCCCCCCCCCC

InChI: InChI=1S/C77H140O17P2/c1-5-9-13-17-21-25-29-33-35-39-42-46-50-54-58-62-75(80)88-68-73(94-77(82)64-60-56-52-48-44-40-36-34-30-26-22-18-14-10-6-2)70-92-96(85,86)90-66-71(78)65-89-95(83,84)91-69-72(93-76(81)63-59-55-51-47-43-38-32-28-24-20-16-12-8-4)67-87-74(79)61-57-53-49-45-41-37-31-27-23-19-15-11-7-3/h9,13,21-22,25-26,33-36,71-73,78H,5-8,10-12,14-20,23-24,27-32,37-70H2,1-4H3,(H,83,84)(H,85,86)/b13-9-,25-21-,26-22-,35-33-,36-34-

Mass to charge: 1397.9

Retention Time: 36.7

11 Molecular Structure

CL 16:1_16:1_18:2_18:2

CHEBI ID: NA

PubChem ID: 138243780

Chemical Formula: C77H138O17P2

Smiles: CCCCCC/C=C\CCCCCCCC(=O)OCC(COP(=O)(O)OCC(COP(=O)(O)OCC(COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC)O)OC(=O)CCCCCCC/C=C\CCCCCC

InChI: InChI=1S/C77H138O17P2/c1-5-9-13-17-21-25-29-33-35-39-42-46-50-54-58-62-75(80)88-68-73(94-77(82)64-60-56-52-48-44-40-36-34-30-26-22-18-14-10-6-2)70-92-96(85,86)90-66-71(78)65-89-95(83,84)91-69-72(93-76(81)63-59-55-51-47-43-38-32-28-24-20-16-12-8-4)67-87-74(79)61-57-53-49-45-41-37-31-27-23-19-15-11-7-3/h21-22,25-28,31-36,71-73,78H,5-20,23-24,29-30,37-70H2,1-4H3,(H,83,84)(H,85,86)/b25-21-,26-22-,31-27-,32-28-,35-33-,36-34-

Mass to charge: 1395.9

Retention Time: 36.1

12 Molecular Structure

CL 16:1_16:1_18:1_18:3/ CL 16:0_16:1_18:2_18:3

CHEBI ID: NA

PubChem ID: 138124283

Chemical Formula: C77H138O17P2

Smiles: CCCCCCCC/C=C\CCCCCCCC(=O)OC(COC(=O)CCCCCCC/C=C\C/C=C\C/C=C\CC)COP(=O)(O)OCC(COP(=O)(O)OCC(COC(=O)CCCCCCC/C=C\CCCCCC)OC(=O)CCCCCCC/C=C\CCCCCC)O

InChI: InChI=1S/C77H138O17P2/c1-5-9-13-17-21-25-29-33-35-39-42-46-50-54-58-62-75(80)88-68-73(94-77(82)64-60-56-52-48-44-40-36-34-30-26-22-18-14-10-6-2)70-92-96(85,86)90-66-71(78)65-89-95(83,84)91-69-72(93-76(81)63-59-55-51-47-43-38-32-28-24-20-16-12-8-4)67-87-74(79)61-57-53-49-45-41-37-31-27-23-19-15-11-7-3/h9,13,21,25,27-28,31-36,71-73,78H,5-8,10-12,14-20,22-24,26,29-30,37-70H2,1-4H3,(H,83,84)(H,85,86)/b13-9-,25-21-,31-27-,32-28-,35-33-,36-34-

Mass to charge: 1395.9

Retention Time: 36.1

13 Molecular Structure

CL 16:0_16:1_16:1_20:5

CHEBI ID: NA

PubChem ID: 138260134

Chemical Formula: C77H134O17P2

Smiles: CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC/C=C\CCCCCC)COP(=O)(O)OCC(COP(=O)(O)OCC(COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCC/C=C\CCCCCC)O

InChI: InChI=1S/C77H136O17P2/c1-5-9-13-17-21-25-29-33-34-35-36-40-42-46-50-54-58-62-75(80)88-68-73(94-77(82)64-60-56-52-48-44-39-32-28-24-20-16-12-8-4)70-92-96(85,86)90-66-71(78)65-89-95(83,84)91-69-72(93-76(81)63-59-55-51-47-43-38-31-27-23-19-15-11-7-3)67-87-74(79)61-57-53-49-45-41-37-30-26-22-18-14-10-6-2/h9,13,21,25-26,28,30,32-34,36,40,46,50,71-73,78H,5-8,10-12,14-20,22-24,27,29,31,35,37-39,41-45,47-49,51-70H2,1-4H3,(H,83,84)(H,85,86)/b13-9-,25-21-,30-26-,32-28-,34-33-,40-36-,50-46-

Mass to charge: 1393.9

Retention Time: 35.4

14 Molecular Structure

CL 16:1_16:1_18:2_18:3/ CL 16:0_16:1_18:3_18:3

CHEBI ID: NA

PubChem ID: 138204520

Chemical Formula: C77H134O17P2

Smiles: CCCCCC/C=C\CCCCCCCC(=O)OCC(COP(=O)(O)OCC(COP(=O)(O)OCC(COC(=O)CCCCCCC/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC)O)OC(=O)CCCCCCC/C=C\CCCCCC

InChI: InChI=1S/C77H136O17P2/c1-5-9-13-17-21-25-29-33-35-39-42-46-50-54-58-62-75(80)88-68-73(94-77(82)64-60-56-52-48-44-40-36-34-30-26-22-18-14-10-6-2)70-92-96(85,86)90-66-71(78)65-89-95(83,84)91-69-72(93-76(81)63-59-55-51-47-43-38-32-28-24-20-16-12-8-4)67-87-74(79)61-57-53-49-45-41-37-31-27-23-19-15-11-7-3/h9,13,21-22,25-28,31-36,71-73,78H,5-8,10-12,14-20,23-24,29-30,37-70H2,1-4H3,(H,83,84)(H,85,86)/b13-9-,25-21-,26-22-,31-27-,32-28-,35-33-,36-34-

Mass to charge: 1393.9

Retention Time: 35.4

15 Molecular Structure

CL 16:1_16:1_16:1_20:5

CHEBI ID: NA

PubChem ID: 138121456

Chemical Formula: C77H134O17P2

Smiles: CCCCCC/C=C\CCCCCCCC(=O)OCC(COP(=O)(O)OCC(COP(=O)(O)OCC(COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCC/C=C\CCCCCC)O)OC(=O)CCCCCCC/C=C\CCCCCC

InChI: InChI=1S/C77H134O17P2/c1-5-9-13-17-21-25-29-33-34-35-36-40-42-46-50-54-58-62-75(80)88-68-73(94-77(82)64-60-56-52-48-44-39-32-28-24-20-16-12-8-4)70-92-96(85,86)90-66-71(78)65-89-95(83,84)91-69-72(93-76(81)63-59-55-51-47-43-38-31-27-23-19-15-11-7-3)67-87-74(79)61-57-53-49-45-41-37-30-26-22-18-14-10-6-2/h9,13,21,25-28,30-34,36,40,46,50,71-73,78H,5-8,10-12,14-20,22-24,29,35,37-39,41-45,47-49,51-70H2,1-4H3,(H,83,84)(H,85,86)/b13-9-,25-21-,30-26-,31-27-,32-28-,34-33-,40-36-,50-46-

Mass to charge: 1391.9

Retention Time: 34.8

16 Molecular Structure

CL 16:1_16:1_18:3_18:3

CHEBI ID: NA

PubChem ID: 138138200

Chemical Formula: C77H134O17P2

Smiles: CCCCCC/C=C\CCCCCCCC(=O)OCC(COP(=O)(O)OCC(COP(=O)(O)OCC(COC(=O)CCCCCCC/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCC/C=C\C/C=C\C/C=C\CC)O)OC(=O)CCCCCCC/C=C\CCCCCC

InChI: InChI=1S/C77H134O17P2/c1-5-9-13-17-21-25-29-33-35-39-42-46-50-54-58-62-75(80)88-68-73(94-77(82)64-60-56-52-48-44-40-36-34-30-26-22-18-14-10-6-2)70-92-96(85,86)90-66-71(78)65-89-95(83,84)91-69-72(93-76(81)63-59-55-51-47-43-38-32-28-24-20-16-12-8-4)67-87-74(79)61-57-53-49-45-41-37-31-27-23-19-15-11-7-3/h9-10,13-14,21-22,25-28,31-36,71-73,78H,5-8,11-12,15-20,23-24,29-30,37-70H2,1-4H3,(H,83,84)(H,85,86)/b13-9-,14-10-,25-21-,26-22-,31-27-,32-28-,35-33-,36-34-

Mass to charge: 1391.9

Retention Time: 34.8

17 Molecular Structure

CL 16:0_18:1_18:1_18:1/ CL 16:1_18:0_18:1_18:1

CHEBI ID: NA

PubChem ID: 138189480

Chemical Formula: C79H148O17P2

Smiles: CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC/C=C\CCCCCCCC)COP(=O)(O)OCC(COP(=O)(O)OCC(COC(=O)CCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC)O

InChI: InChI=1S/C79H148O17P2/c1-5-9-13-17-21-25-29-33-36-40-43-47-51-55-59-63-76(81)89-69-74(95-78(83)65-61-57-53-49-45-39-32-28-24-20-16-12-8-4)71-93-97(85,86)91-67-73(80)68-92-98(87,88)94-72-75(96-79(84)66-62-58-54-50-46-42-38-35-31-27-23-19-15-11-7-3)70-90-77(82)64-60-56-52-48-44-41-37-34-30-26-22-18-14-10-6-2/h33-38,73-75,80H,5-32,39-72H2,1-4H3,(H,85,86)(H,87,88)/b36-33-,37-34-,38-35-

Mass to charge: 1430.1

Retention Time: 38.8

18 Molecular Structure

CL 16:0_18:0_18:0_18:3

CHEBI ID: NA

PubChem ID: 138262338

Chemical Formula: C79H148O17P2

Smiles: CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(COP(=O)(O)OCC(COC(=O)CCCCCCC/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCCCCCCCCCCCC)O)OC(=O)CCCCCCCCCCCCCCC

InChI: InChI=1S/C79H148O17P2/c1-5-9-13-17-21-25-29-33-36-40-43-47-51-55-59-63-76(81)89-69-74(95-78(83)65-61-57-53-49-45-39-32-28-24-20-16-12-8-4)71-93-97(85,86)91-67-73(80)68-92-98(87,88)94-72-75(96-79(84)66-62-58-54-50-46-42-38-35-31-27-23-19-15-11-7-3)70-90-77(82)64-60-56-52-48-44-41-37-34-30-26-22-18-14-10-6-2/h10,14,22,26,34,37,73-75,80H,5-9,11-13,15-21,23-25,27-33,35-36,38-72H2,1-4H3,(H,85,86)(H,87,88)/b14-10-,26-22-,37-34-

Mass to charge: 1430.1

Retention Time: 38.8

19 Molecular Structure

CL 16:0_18:1_18:1_18:2

CHEBI ID: NA

PubChem ID: 138120190

Chemical Formula: C79H146O17P2

Smiles: CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC/C=C\CCCCCCCC)COP(=O)(O)OCC(COP(=O)(O)OCC(COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC)O

InChI: InChI=1S/C79H146O17P2/c1-5-9-13-17-21-25-29-33-36-40-43-47-51-55-59-63-76(81)89-69-74(95-78(83)65-61-57-53-49-45-39-32-28-24-20-16-12-8-4)71-93-97(85,86)91-67-73(80)68-92-98(87,88)94-72-75(96-79(84)66-62-58-54-50-46-42-38-35-31-27-23-19-15-11-7-3)70-90-77(82)64-60-56-52-48-44-41-37-34-30-26-22-18-14-10-6-2/h22,26,33-38,73-75,80H,5-21,23-25,27-32,39-72H2,1-4H3,(H,85,86)(H,87,88)/b26-22-,36-33-,37-34-,38-35-

Mass to charge: 1427.9

Retention Time: 38.7

20 Molecular Structure

CL 16:1_18:0_18:0_18:3/ CL 16:0_18:0_18:1_18:3

CHEBI ID: NA

PubChem ID: 138289954

Chemical Formula: C79H146O17P2

Smiles: CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(COP(=O)(O)OCC(COC(=O)CCCCCCC/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCCCCCCCCCCCC)O)OC(=O)CCCCCCC/C=C\CCCCCC

InChI: InChI=1S/C79H146O17P2/c1-5-9-13-17-21-25-29-33-36-40-43-47-51-55-59-63-76(81)89-69-74(95-78(83)65-61-57-53-49-45-39-32-28-24-20-16-12-8-4)71-93-97(85,86)91-67-73(80)68-92-98(87,88)94-72-75(96-79(84)66-62-58-54-50-46-42-38-35-31-27-23-19-15-11-7-3)70-90-77(82)64-60-56-52-48-44-41-37-34-30-26-22-18-14-10-6-2/h10,14,22,26,28,32,34,37,73-75,80H,5-9,11-13,15-21,23-25,27,29-31,33,35-36,38-72H2,1-4H3,(H,85,86)(H,87,88)/b14-10-,26-22-,32-28-,37-34-

Mass to charge: 1427.9

Retention Time: 38.7

21 Molecular Structure

CL 16:1_18:1_18:1_18:2

CHEBI ID: NA

PubChem ID: 138255015

Chemical Formula: C79H144O17P2

Smiles: CCCCCCCC/C=C\CCCCCCCC(=O)OCC(COP(=O)(O)OCC(COP(=O)(O)OCC(COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC)O)OC(=O)CCCCCCC/C=C\CCCCCC

InChI: InChI=1S/C79H144O17P2/c1-5-9-13-17-21-25-29-33-36-40-43-47-51-55-59-63-76(81)89-69-74(95-78(83)65-61-57-53-49-45-39-32-28-24-20-16-12-8-4)71-93-97(85,86)91-67-73(80)68-92-98(87,88)94-72-75(96-79(84)66-62-58-54-50-46-42-38-35-31-27-23-19-15-11-7-3)70-90-77(82)64-60-56-52-48-44-41-37-34-30-26-22-18-14-10-6-2/h22,26,28,32-38,73-75,80H,5-21,23-25,27,29-31,39-72H2,1-4H3,(H,85,86)(H,87,88)/b26-22-,32-28-,36-33-,37-34-,38-35-

Mass to charge: 1425.9

Retention Time: 37.8

22 Molecular Structure

CL 16:0_18:1_18:1_18:3/ CL 16:1_18:0_18:1_18:3

CHEBI ID: NA

PubChem ID: 138191131

Chemical Formula: C79H144O17P2

Smiles: CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC/C=C\CCCCCCCC)COP(=O)(O)OCC(COP(=O)(O)OCC(COC(=O)CCCCCCC/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCC/C=C\CCCCCCCC)O

InChI: InChI=1S/C79H144O17P2/c1-5-9-13-17-21-25-29-33-36-40-43-47-51-55-59-63-76(81)89-69-74(95-78(83)65-61-57-53-49-45-39-32-28-24-20-16-12-8-4)71-93-97(85,86)91-67-73(80)68-92-98(87,88)94-72-75(96-79(84)66-62-58-54-50-46-42-38-35-31-27-23-19-15-11-7-3)70-90-77(82)64-60-56-52-48-44-41-37-34-30-26-22-18-14-10-6-2/h10,14,22,26,33-38,73-75,80H,5-9,11-13,15-21,23-25,27-32,39-72H2,1-4H3,(H,85,86)(H,87,88)/b14-10-,26-22-,36-33-,37-34-,38-35-

Mass to charge: 1425.9

Retention Time: 37.8

23 Molecular Structure

CL 16:1_18:1_18:2_18:2

CHEBI ID: NA

PubChem ID: 138209519

Chemical Formula: C79H142O17P2

Smiles: CCCCCCCC/C=C\CCCCCCCC(=O)OCC(COP(=O)(O)OCC(COP(=O)(O)OCC(COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC)O)OC(=O)CCCCCCC/C=C\CCCCCC

InChI: InChI=1S/C79H142O17P2/c1-5-9-13-17-21-25-29-33-36-40-43-47-51-55-59-63-76(81)89-69-74(95-78(83)65-61-57-53-49-45-39-32-28-24-20-16-12-8-4)71-93-97(85,86)91-67-73(80)68-92-98(87,88)94-72-75(96-79(84)66-62-58-54-50-46-42-38-35-31-27-23-19-15-11-7-3)70-90-77(82)64-60-56-52-48-44-41-37-34-30-26-22-18-14-10-6-2/h22-23,26-28,32-38,73-75,80H,5-21,24-25,29-31,39-72H2,1-4H3,(H,85,86)(H,87,88)/b26-22-,27-23-,32-28-,36-33-,37-34-,38-35-

Mass to charge: 1423.9

Retention Time: 37.0

24 Molecular Structure

CL 16:1_18:1_18:1_18:3/ CL 16:0_18:0_18:3_18:3

CHEBI ID: NA

PubChem ID: 138236342

Chemical Formula: C79H142O17P2

Smiles: CCCCCCCC/C=C\CCCCCCCC(=O)OCC(COP(=O)(O)OCC(COP(=O)(O)OCC(COC(=O)CCCCCCC/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCC/C=C\CCCCCCCC)O)OC(=O)CCCCCCC/C=C\CCCCCC

InChI: InChI=1S/C79H142O17P2/c1-5-9-13-17-21-25-29-33-36-40-43-47-51-55-59-63-76(81)89-69-74(95-78(83)65-61-57-53-49-45-39-32-28-24-20-16-12-8-4)71-93-97(85,86)91-67-73(80)68-92-98(87,88)94-72-75(96-79(84)66-62-58-54-50-46-42-38-35-31-27-23-19-15-11-7-3)70-90-77(82)64-60-56-52-48-44-41-37-34-30-26-22-18-14-10-6-2/h10,14,22,26,28,32-38,73-75,80H,5-9,11-13,15-21,23-25,27,29-31,39-72H2,1-4H3,(H,85,86)(H,87,88)/b14-10-,26-22-,32-28-,36-33-,37-34-,38-35-

Mass to charge: 1423.9

Retention Time: 37.0

25 Molecular Structure

CL 16:1_18:2_18:2_18:2

CHEBI ID: NA

PubChem ID: 138126603

Chemical Formula: C79H140O17P2

Smiles: CCCCCC/C=C\CCCCCCCC(=O)OC(COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)COP(=O)(O)OCC(COP(=O)(O)OCC(COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC)O

InChI: InChI=1S/C79H140O17P2/c1-5-9-13-17-21-25-29-33-36-40-43-47-51-55-59-63-76(81)89-69-74(95-78(83)65-61-57-53-49-45-39-32-28-24-20-16-12-8-4)71-93-97(85,86)91-67-73(80)68-92-98(87,88)94-72-75(96-79(84)66-62-58-54-50-46-42-38-35-31-27-23-19-15-11-7-3)70-90-77(82)64-60-56-52-48-44-41-37-34-30-26-22-18-14-10-6-2/h21-23,25-28,32-38,73-75,80H,5-20,24,29-31,39-72H2,1-4H3,(H,85,86)(H,87,88)/b25-21-,26-22-,27-23-,32-28-,36-33-,37-34-,38-35-

Mass to charge: 1421.9

Retention Time: 36.4

26 Molecular Structure

CL 16:1_18:1_18:2_18:3/ CL 16:1_18:0_18:3_18:3

CHEBI ID: NA

PubChem ID: 138223876

Chemical Formula: C79H140O17P2

Smiles: CCCCCCCC/C=C\CCCCCCCC(=O)OCC(COP(=O)(O)OCC(COP(=O)(O)OCC(COC(=O)CCCCCCC/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC)O)OC(=O)CCCCCCC/C=C\CCCCCC

InChI: InChI=1S/C79H140O17P2/c1-5-9-13-17-21-25-29-33-36-40-43-47-51-55-59-63-76(81)89-69-74(95-78(83)65-61-57-53-49-45-39-32-28-24-20-16-12-8-4)71-93-97(85,86)91-67-73(80)68-92-98(87,88)94-72-75(96-79(84)66-62-58-54-50-46-42-38-35-31-27-23-19-15-11-7-3)70-90-77(82)64-60-56-52-48-44-41-37-34-30-26-22-18-14-10-6-2/h10,14,22-23,26-28,32-38,73-75,80H,5-9,11-13,15-21,24-25,29-31,39-72H2,1-4H3,(H,85,86)(H,87,88)/b14-10-,26-22-,27-23-,32-28-,36-33-,37-34-,38-35-

Mass to charge: 1421.9

Retention Time: 36.4

27 Molecular Structure

CL 16:1_16:1_18:2_20:4

CHEBI ID: NA

PubChem ID: 138184641

Chemical Formula: C79H138O17P2

Smiles: CCCCCC/C=C\CCCCCCCC(=O)OCC(COP(=O)(O)OCC(COP(=O)(O)OCC(COC(=O)CCCCCC/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC)O)OC(=O)CCCCCCC/C=C\CCCCCC

InChI: InChI=1S/C79H138O17P2/c1-5-9-13-17-21-25-29-33-35-36-38-41-44-48-52-56-60-64-77(82)90-70-75(96-79(84)66-62-58-54-50-46-42-37-34-30-26-22-18-14-10-6-2)72-94-98(87,88)92-68-73(80)67-91-97(85,86)93-71-74(95-78(83)65-61-57-53-49-45-40-32-28-24-20-16-12-8-4)69-89-76(81)63-59-55-51-47-43-39-31-27-23-19-15-11-7-3/h9,13,21-22,25-28,31-35,37-38,41,73-75,80H,5-8,10-12,14-20,23-24,29-30,36,39-40,42-72H2,1-4H3,(H,85,86)(H,87,88)/b13-9-,25-21-,26-22-,31-27-,32-28-,35-33-,37-34-,41-38-

Mass to charge: 1419.9

Retention Time: 35.7

28 Molecular Structure

CL 16:1_18:1_18:3_18:3

CHEBI ID: NA

PubChem ID: 138261175

Chemical Formula: C79H138O17P2

Smiles: CCCCCCCC/C=C\CCCCCCCC(=O)OCC(COP(=O)(O)OCC(COP(=O)(O)OCC(COC(=O)CCCCCCC/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCC/C=C\C/C=C\C/C=C\CC)O)OC(=O)CCCCCCC/C=C\CCCCCC

InChI: InChI=1S/C79H138O17P2/c1-5-9-13-17-21-25-29-33-36-40-43-47-51-55-59-63-76(81)89-69-74(95-78(83)65-61-57-53-49-45-39-32-28-24-20-16-12-8-4)71-93-97(85,86)91-67-73(80)68-92-98(87,88)94-72-75(96-79(84)66-62-58-54-50-46-42-38-35-31-27-23-19-15-11-7-3)70-90-77(82)64-60-56-52-48-44-41-37-34-30-26-22-18-14-10-6-2/h10-11,14-15,22-23,26-28,32-38,73-75,80H,5-9,12-13,16-21,24-25,29-31,39-72H2,1-4H3,(H,85,86)(H,87,88)/b14-10-,15-11-,26-22-,27-23-,32-28-,36-33-,37-34-,38-35-

Mass to charge: 1419.9

Retention Time: 35.7

29 Molecular Structure

CL 16:1_16:1_18:2_20:5

CHEBI ID: NA

PubChem ID: 138205119

Chemical Formula: C79H136O17P2

Smiles: CCCCCC/C=C\CCCCCCCC(=O)OCC(COP(=O)(O)OCC(COP(=O)(O)OCC(COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC)O)OC(=O)CCCCCCC/C=C\CCCCCC

InChI: InChI=1S/C79H136O17P2/c1-5-9-13-17-21-25-29-33-35-36-38-41-44-48-52-56-60-64-77(82)90-70-75(96-79(84)66-62-58-54-50-46-42-37-34-30-26-22-18-14-10-6-2)72-94-98(87,88)92-68-73(80)67-91-97(85,86)93-71-74(95-78(83)65-61-57-53-49-45-40-32-28-24-20-16-12-8-4)69-89-76(81)63-59-55-51-47-43-39-31-27-23-19-15-11-7-3/h9,13,21-22,25-28,31-35,37-38,41,48,52,73-75,80H,5-8,10-12,14-20,23-24,29-30,36,39-40,42-47,49-51,53-72H2,1-4H3,(H,85,86)(H,87,88)/b13-9-,25-21-,26-22-,31-27-,32-28-,35-33-,37-34-,41-38-,52-48-

Mass to charge: 1417.9

Retention Time: 35.3

30 Molecular Structure

CL 16:1_18:2_18:3_18:3

CHEBI ID: NA

PubChem ID: 138156108

Chemical Formula: C79H136O17P2

Smiles: CCCCCC/C=C\CCCCCCCC(=O)OC(COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)COP(=O)(O)OCC(COP(=O)(O)OCC(COC(=O)CCCCCCC/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCC/C=C\C/C=C\C/C=C\CC)O

InChI: InChI=1S/C79H136O17P2/c1-5-9-13-17-21-25-29-33-36-40-43-47-51-55-59-63-76(81)89-69-74(95-78(83)65-61-57-53-49-45-39-32-28-24-20-16-12-8-4)71-93-97(85,86)91-67-73(80)68-92-98(87,88)94-72-75(96-79(84)66-62-58-54-50-46-42-38-35-31-27-23-19-15-11-7-3)70-90-77(82)64-60-56-52-48-44-41-37-34-30-26-22-18-14-10-6-2/h10-11,14-15,21-23,25-28,32-38,73-75,80H,5-9,12-13,16-20,24,29-31,39-72H2,1-4H3,(H,85,86)(H,87,88)/b14-10-,15-11-,25-21-,26-22-,27-23-,32-28-,36-33-,37-34-,38-35-

Mass to charge: 1417.9

Retention Time: 35.3

31 Molecular Structure

CL 16:1_18:3_18:3_18:3

CHEBI ID: NA

PubChem ID: 138240999

Chemical Formula: C79H134O17P2

Smiles: CCCCCC/C=C\CCCCCCCC(=O)OC(COC(=O)CCCCCCC/C=C\C/C=C\C/C=C\CC)COP(=O)(O)OCC(COP(=O)(O)OCC(COC(=O)CCCCCCC/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCC/C=C\C/C=C\C/C=C\CC)O

InChI: InChI=1S/C79H134O17P2/c1-5-9-13-17-21-25-29-33-36-40-43-47-51-55-59-63-76(81)89-69-74(95-78(83)65-61-57-53-49-45-39-32-28-24-20-16-12-8-4)71-93-97(85,86)91-67-73(80)68-92-98(87,88)94-72-75(96-79(84)66-62-58-54-50-46-42-38-35-31-27-23-19-15-11-7-3)70-90-77(82)64-60-56-52-48-44-41-37-34-30-26-22-18-14-10-6-2/h9-11,13-15,21-23,25-28,32-38,73-75,80H,5-8,12,16-20,24,29-31,39-72H2,1-4H3,(H,85,86)(H,87,88)/b13-9-,14-10-,15-11-,25-21-,26-22-,27-23-,32-28-,36-33-,37-34-,38-35-

Mass to charge: 1415.9

Retention Time: 34.6

32 Molecular Structure

CL 18:1_18:1_18:1_18:1

CHEBI ID: NA

PubChem ID: 10464221

Chemical Formula: C81H150O17P2

Smiles: CCCCCCCC/C=C\CCCCCCCC(=O)OCC(OC(=O)CCCCCCC/C=C\CCCCCCCC)COP(=O)(OCC(O)COP(=O)(OCC(OC(=O)CCCCCCC/C=C\CCCCCCCC)COC(=O)CCCCCCC/C=C\CCCCCCCC)O)O

InChI: InChI=1S/C81H150O17P2/c1-5-9-13-17-21-25-29-33-37-41-45-49-53-57-61-65-78(83)91-71-76(97-80(85)67-63-59-55-51-47-43-39-35-31-27-23-19-15-11-7-3)73-95-99(87,88)93-69-75(82)70-94-100(89,90)96-74-77(98-81(86)68-64-60-56-52-48-44-40-36-32-28-24-20-16-12-8-4)72-92-79(84)66-62-58-54-50-46-42-38-34-30-26-22-18-14-10-6-2/h33-40,75-77,82H,5-32,41-74H2,1-4H3,(H,87,88)(H,89,90)/b37-33-,38-34-,39-35-,40-36-

Mass to charge: 1456.1

Retention Time: 40.3

33 Molecular Structure

CL 18:1_18:1_18:1_18:2/ CL 18:0_18:1_18:2_18:2

CHEBI ID: NA

PubChem ID: 138173202

Chemical Formula: C81H148O17P2

Smiles: CCCCCCCC/C=C\CCCCCCCC(=O)OCC(COP(=O)(O)OCC(COP(=O)(O)OCC(COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC)O)OC(=O)CCCCCCC/C=C\CCCCCCCC

InChI: InChI=1S/C81H148O17P2/c1-5-9-13-17-21-25-29-33-37-41-45-49-53-57-61-65-78(83)91-71-76(97-80(85)67-63-59-55-51-47-43-39-35-31-27-23-19-15-11-7-3)73-95-99(87,88)93-69-75(82)70-94-100(89,90)96-74-77(98-81(86)68-64-60-56-52-48-44-40-36-32-28-24-20-16-12-8-4)72-92-79(84)66-62-58-54-50-46-42-38-34-30-26-22-18-14-10-6-2/h21,25,33-40,75-77,82H,5-20,22-24,26-32,41-74H2,1-4H3,(H,87,88)(H,89,90)/b25-21-,37-33-,38-34-,39-35-,40-36-

Mass to charge: 1454.1

Retention Time: 39.3

34 Molecular Structure

CL 18:1_18:1_18:2_18:2

CHEBI ID: NA

PubChem ID: 138243779

Chemical Formula: C81H146O17P2

Smiles: CCCCCCCC/C=C\CCCCCCCC(=O)OCC(COP(=O)(O)OCC(COP(=O)(O)OCC(COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC)O)OC(=O)CCCCCCC/C=C\CCCCCCCC

InChI: InChI=1S/C81H146O17P2/c1-5-9-13-17-21-25-29-33-37-41-45-49-53-57-61-65-78(83)91-71-76(97-80(85)67-63-59-55-51-47-43-39-35-31-27-23-19-15-11-7-3)73-95-99(87,88)93-69-75(82)70-94-100(89,90)96-74-77(98-81(86)68-64-60-56-52-48-44-40-36-32-28-24-20-16-12-8-4)72-92-79(84)66-62-58-54-50-46-42-38-34-30-26-22-18-14-10-6-2/h21,23,25,27,33-40,75-77,82H,5-20,22,24,26,28-32,41-74H2,1-4H3,(H,87,88)(H,89,90)/b25-21-,27-23-,37-33-,38-34-,39-35-,40-36-

Mass to charge: 1451.9

Retention Time: 38.4

35 Molecular Structure

CL 18:1_18:1_18:1_18:3

CHEBI ID: NA

PubChem ID: 138129457

Chemical Formula: C81H146O17P2

Smiles: CCCCCCCC/C=C\CCCCCCCC(=O)OCC(COP(=O)(O)OCC(COP(=O)(O)OCC(COC(=O)CCCCCCC/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCC/C=C\CCCCCCCC)O)OC(=O)CCCCCCC/C=C\CCCCCCCC

InChI: InChI=1S/C81H146O17P2/c1-5-9-13-17-21-25-29-33-37-41-45-49-53-57-61-65-78(83)91-71-76(97-80(85)67-63-59-55-51-47-43-39-35-31-27-23-19-15-11-7-3)73-95-99(87,88)93-69-75(82)70-94-100(89,90)96-74-77(98-81(86)68-64-60-56-52-48-44-40-36-32-28-24-20-16-12-8-4)72-92-79(84)66-62-58-54-50-46-42-38-34-30-26-22-18-14-10-6-2/h9,13,21,25,33-40,75-77,82H,5-8,10-12,14-20,22-24,26-32,41-74H2,1-4H3,(H,87,88)(H,89,90)/b13-9-,25-21-,37-33-,38-34-,39-35-,40-36-

Mass to charge: 1451.9

Retention Time: 38.4

36 Molecular Structure

CL 18:1_18:2_18:2_18:2

CHEBI ID: NA

PubChem ID: 138291263

Chemical Formula: C81H144O17P2

Smiles: CCCCCCCC/C=C\CCCCCCCC(=O)OC(COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)COP(=O)(O)OCC(COP(=O)(O)OCC(COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC)O

InChI: InChI=1S/C81H144O17P2/c1-5-9-13-17-21-25-29-33-37-41-45-49-53-57-61-65-78(83)91-71-76(97-80(85)67-63-59-55-51-47-43-39-35-31-27-23-19-15-11-7-3)73-95-99(87,88)93-69-75(82)70-94-100(89,90)96-74-77(98-81(86)68-64-60-56-52-48-44-40-36-32-28-24-20-16-12-8-4)72-92-79(84)66-62-58-54-50-46-42-38-34-30-26-22-18-14-10-6-2/h21-23,25-27,33-40,75-77,82H,5-20,24,28-32,41-74H2,1-4H3,(H,87,88)(H,89,90)/b25-21-,26-22-,27-23-,37-33-,38-34-,39-35-,40-36-

Mass to charge: 1449.9

Retention Time: 37.4

37 Molecular Structure

CL 18:1_18:1_18:2_18:3/ CL 18:0_18:1_18:3_18:3

CHEBI ID: NA

PubChem ID: 138146604

Chemical Formula: C81H144O17P2

Smiles: CCCCCCCC/C=C\CCCCCCCC(=O)OCC(COP(=O)(O)OCC(COP(=O)(O)OCC(COC(=O)CCCCCCC/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC)O)OC(=O)CCCCCCC/C=C\CCCCCCCC

InChI: InChI=1S/C81H144O17P2/c1-5-9-13-17-21-25-29-33-37-41-45-49-53-57-61-65-78(83)91-71-76(97-80(85)67-63-59-55-51-47-43-39-35-31-27-23-19-15-11-7-3)73-95-99(87,88)93-69-75(82)70-94-100(89,90)96-74-77(98-81(86)68-64-60-56-52-48-44-40-36-32-28-24-20-16-12-8-4)72-92-79(84)66-62-58-54-50-46-42-38-34-30-26-22-18-14-10-6-2/h9,13,21,23,25,27,33-40,75-77,82H,5-8,10-12,14-20,22,24,26,28-32,41-74H2,1-4H3,(H,87,88)(H,89,90)/b13-9-,25-21-,27-23-,37-33-,38-34-,39-35-,40-36-

Mass to charge: 1449.9

Retention Time: 37.4

38 Molecular Structure

CL 18:2_18:2_18:2_18:2

CHEBI ID: NA

PubChem ID: 138205444

Chemical Formula: C81H142O17P2

Smiles: CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCC(OC(=O)CCCCCCC/C=C\C/C=C\CCCCC)COP(=O)(OCC(O)COP(=O)(OCC(OC(=O)CCCCCCC/C=C\C/C=C\CCCCC)COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)O)O

InChI: InChI=1S/C81H142O17P2/c1-5-9-13-17-21-25-29-33-37-41-45-49-53-57-61-65-78(83)91-71-76(97-80(85)67-63-59-55-51-47-43-39-35-31-27-23-19-15-11-7-3)73-95-99(87,88)93-69-75(82)70-94-100(89,90)96-74-77(98-81(86)68-64-60-56-52-48-44-40-36-32-28-24-20-16-12-8-4)72-92-79(84)66-62-58-54-50-46-42-38-34-30-26-22-18-14-10-6-2/h21-28,33-40,75-77,82H,5-20,29-32,41-74H2,1-4H3,(H,87,88)(H,89,90)/b25-21-,26-22-,27-23-,28-24-,37-33-,38-34-,39-35-,40-36-

Mass to charge: 1447.9

Retention Time: 36.7

39 Molecular Structure

CL 18:1_18:1_18:3_18:3

CHEBI ID: NA

PubChem ID: 138164840

Chemical Formula: C81H142O17P2

Smiles: CCCCCCCC/C=C\CCCCCCCC(=O)OCC(COP(=O)(O)OCC(COP(=O)(O)OCC(COC(=O)CCCCCCC/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCC/C=C\C/C=C\C/C=C\CC)O)OC(=O)CCCCCCC/C=C\CCCCCCCC

InChI: InChI=1S/C81H142O17P2/c1-5-9-13-17-21-25-29-33-37-41-45-49-53-57-61-65-78(83)91-71-76(97-80(85)67-63-59-55-51-47-43-39-35-31-27-23-19-15-11-7-3)73-95-99(87,88)93-69-75(82)70-94-100(89,90)96-74-77(98-81(86)68-64-60-56-52-48-44-40-36-32-28-24-20-16-12-8-4)72-92-79(84)66-62-58-54-50-46-42-38-34-30-26-22-18-14-10-6-2/h9,11,13,15,21,23,25,27,33-40,75-77,82H,5-8,10,12,14,16-20,22,24,26,28-32,41-74H2,1-4H3,(H,87,88)(H,89,90)/b13-9-,15-11-,25-21-,27-23-,37-33-,38-34-,39-35-,40-36-

Mass to charge: 1447.9

Retention Time: 36.7

40 Molecular Structure

CL 16:0_18:2_18:2_20:5/ CL 16:1_18:1_18:2_20:5

CHEBI ID: NA

PubChem ID: 138279561

Chemical Formula: C81H140O17P2

Smiles: CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)COP(=O)(O)OCC(COP(=O)(O)OCC(COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC)O

InChI: InChI=1S/C81H140O17P2/c1-5-9-13-17-21-25-29-33-36-37-40-43-46-50-54-58-62-66-79(84)92-72-77(98-81(86)68-64-60-56-52-48-44-39-35-31-27-23-19-15-11-7-3)74-96-100(89,90)94-70-75(82)69-93-99(87,88)95-73-76(97-80(85)67-63-59-55-51-47-41-32-28-24-20-16-12-8-4)71-91-78(83)65-61-57-53-49-45-42-38-34-30-26-22-18-14-10-6-2/h9,13,21-23,25-27,33-36,38-40,43,50,54,75-77,82H,5-8,10-12,14-20,24,28-32,37,41-42,44-49,51-53,55-74H2,1-4H3,(H,87,88)(H,89,90)/b13-9-,25-21-,26-22-,27-23-,36-33-,38-34-,39-35-,43-40-,54-50-

Mass to charge: 1445.9

Retention Time: 36.1

41 Molecular Structure

CL 18:2_18:2_18:2_18:3

CHEBI ID: NA

PubChem ID: 138293711

Chemical Formula: C81H140O17P2

Smiles: CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCC(COP(=O)(O)OCC(COP(=O)(O)OCC(COC(=O)CCCCCCC/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC)O)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC

InChI: InChI=1S/C81H140O17P2/c1-5-9-13-17-21-25-29-33-37-41-45-49-53-57-61-65-78(83)91-71-76(97-80(85)67-63-59-55-51-47-43-39-35-31-27-23-19-15-11-7-3)73-95-99(87,88)93-69-75(82)70-94-100(89,90)96-74-77(98-81(86)68-64-60-56-52-48-44-40-36-32-28-24-20-16-12-8-4)72-92-79(84)66-62-58-54-50-46-42-38-34-30-26-22-18-14-10-6-2/h9,13,21-28,33-40,75-77,82H,5-8,10-12,14-20,29-32,41-74H2,1-4H3,(H,87,88)(H,89,90)/b13-9-,25-21-,26-22-,27-23-,28-24-,37-33-,38-34-,39-35-,40-36-

Mass to charge: 1445.9

Retention Time: 36.1

42 Molecular Structure

CL 16:1_18:2_18:2_20:5

CHEBI ID: NA

PubChem ID: 138173105

Chemical Formula: C81H138O17P2

Smiles: CCCCCC/C=C\CCCCCCCC(=O)OC(COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)COP(=O)(O)OCC(COP(=O)(O)OCC(COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC)O

InChI: InChI=1S/C81H138O17P2/c1-5-9-13-17-21-25-29-33-36-37-40-43-46-50-54-58-62-66-79(84)92-72-77(98-81(86)68-64-60-56-52-48-44-39-35-31-27-23-19-15-11-7-3)74-96-100(89,90)94-70-75(82)69-93-99(87,88)95-73-76(97-80(85)67-63-59-55-51-47-41-32-28-24-20-16-12-8-4)71-91-78(83)65-61-57-53-49-45-42-38-34-30-26-22-18-14-10-6-2/h9,13,21-23,25-28,32-36,38-40,43,50,54,75-77,82H,5-8,10-12,14-20,24,29-31,37,41-42,44-49,51-53,55-74H2,1-4H3,(H,87,88)(H,89,90)/b13-9-,25-21-,26-22-,27-23-,32-28-,36-33-,38-34-,39-35-,43-40-,54-50-

Mass to charge: 1443.9

Retention Time: 35.5

43 Molecular Structure

CL 18:2_18:2_18:3_18:3/ CL 18:1_18:3_18:3_18:3

CHEBI ID: NA

PubChem ID: 138157089

Chemical Formula: C81H138O17P2

Smiles: CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCC(COP(=O)(O)OCC(COP(=O)(O)OCC(COC(=O)CCCCCCC/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCC/C=C\C/C=C\C/C=C\CC)O)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC

InChI: InChI=1S/C81H138O17P2/c1-5-9-13-17-21-25-29-33-37-41-45-49-53-57-61-65-78(83)91-71-76(97-80(85)67-63-59-55-51-47-43-39-35-31-27-23-19-15-11-7-3)73-95-99(87,88)93-69-75(82)70-94-100(89,90)96-74-77(98-81(86)68-64-60-56-52-48-44-40-36-32-28-24-20-16-12-8-4)72-92-79(84)66-62-58-54-50-46-42-38-34-30-26-22-18-14-10-6-2/h9,11,13,15,21-28,33-40,75-77,82H,5-8,10,12,14,16-20,29-32,41-74H2,1-4H3,(H,87,88)(H,89,90)/b13-9-,15-11-,25-21-,26-22-,27-23-,28-24-,37-33-,38-34-,39-35-,40-36-

Mass to charge: 1443.9

Retention Time: 35.5

44 Molecular Structure

CL 18:2_18:3_18:3_18:3

CHEBI ID: NA

PubChem ID: 138158086

Chemical Formula: C81H136O17P2

Smiles: CCCCC/C=C\C/C=C\CCCCCCCC(=O)OC(COC(=O)CCCCCCC/C=C\C/C=C\C/C=C\CC)COP(=O)(O)OCC(COP(=O)(O)OCC(COC(=O)CCCCCCC/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCC/C=C\C/C=C\C/C=C\CC)O

InChI: InChI=1S/C81H136O17P2/c1-5-9-13-17-21-25-29-33-37-41-45-49-53-57-61-65-78(83)91-71-76(97-80(85)67-63-59-55-51-47-43-39-35-31-27-23-19-15-11-7-3)73-95-99(87,88)93-69-75(82)70-94-100(89,90)96-74-77(98-81(86)68-64-60-56-52-48-44-40-36-32-28-24-20-16-12-8-4)72-92-79(84)66-62-58-54-50-46-42-38-34-30-26-22-18-14-10-6-2/h9-11,13-15,21-28,33-40,75-77,82H,5-8,12,16-20,29-32,41-74H2,1-4H3,(H,87,88)(H,89,90)/b13-9-,14-10-,15-11-,25-21-,26-22-,27-23-,28-24-,37-33-,38-34-,39-35-,40-36-

Mass to charge: 1441.9

Retention Time: 34.8

45 Molecular Structure

CL 14:0_14:0_14:0_14:0

CHEBI ID: NA

PubChem ID: 131797799

Chemical Formula: C65H126O17P2

Smiles: CC(C)CCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCC(COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCC(C)C)O)OC(=O)CCCCCCCCCCC(C)C

InChI: InChI=1S/C65H126O17P2/c1-55(2)41-33-25-17-9-13-21-29-37-45-62(67)75-51-60(81-64(69)47-39-31-23-15-11-19-27-35-43-57(5)6)53-79-83(71,72)77-49-59(66)50-78-84(73,74)80-54-61(82-65(70)48-40-32-24-16-12-20-28-36-44-58(7)8)52-76-63(68)46-38-30-22-14-10-18-26-34-42-56(3)4/h55-61,66H,9-54H2,1-8H3,(H,71,72)(H,73,74)/t60-,61-/m1/s1

Mass to charge: 1239.9

Retention Time: 34.2